Abiopharma

STANDEX INTERNATIONAL CORP/DE/ (SXI)

Symbol	SXI
Name	STANDEX INTERNATIONAL CORP/DE/
Sector	INDUSTRIALS
Region	North America
Industry	Refrigeration & Service Industry Machinery
Address	23 KEEWAYDIN DRIVE, SALEM, NH 03079
Telephone	603-893-9701
Fax	—
Email	—
Website	https://www.standex.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0000310354
Description	Standex International Corp is a US-based firm. It engages in manufacturing a variety of products and services for several commercial and industrial markets. It has five segments that include Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. With its business spread majorly in the United States, most of the company revenues come from the Electronics business that primarily includes manufacturing and selling of electronic components for applications throughout the end-user market spectrum. Additional info from NASDAQ: Standex International Corp is a US-based firm. It engages in manufacturing a variety of products and services for several commercial and industrial markets. It has five segments that include Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. With its business spread majorly in the United States, most of the company revenues come from the Electronics business that primarily includes manufacturing and selling of electronic components for applications throughout the end-user market spectrum.

2026-08-12 21:15

Slaughter Richard Colby 🟢 acquired 2.3K shares (1 derivative) of STANDEX INTERNATIONAL CORP/DE/ (SXI) Transaction Date: Aug 10, 2026 | Filing ID: 000060

2026-08-12 18:11

New Form 3 - STANDEX INTERNATIONAL CORP/DE/ Filed: 2026-08-12 AccNo: 0000310354-26-000058 Size: 6 KB

2026-08-11 18:55

New Form 5 - STANDEX INTERNATIONAL CORP/DE/ Filed: 2026-08-11 AccNo: 0000310354-26-000049 Size: 15 KB

2026-08-11 18:54

New Form 5 - STANDEX INTERNATIONAL CORP/DE/ Filed: 2026-08-11 AccNo: 0000310354-26-000047 Size: 7 KB

2026-08-11 18:52

New Form 5 - STANDEX INTERNATIONAL CORP/DE/ Filed: 2026-08-11 AccNo: 0000310354-26-000045 Size: 7 KB

2026-08-05 12:30

STANDEX TO PARTICIPATE IN D.A. DAVIDSON SMALL CAP VIRTUAL CONFERENCE

2026-08-03 17:20

📋 CHORMAN THOMAS E (Director) plans to sell 50 shares of STANDEX INTERNATIONAL CORP/DE/ (at $305.56 each, total $15K) Filed: Aug 03, 2026 | ID: 005525

2026-07-30 20:01

STANDEX REPORTS FISCAL FOURTH QUARTER AND FISCAL YEAR 2026 FINANCIAL RESULTS

2026-07-24 12:30

STANDEX ANNOUNCES TIMING OF FOURTH QUARTER FISCAL 2026 RESULTS

2026-07-23 12:18

STANDEX DECLARES 248th CONSECUTIVE QUARTERLY DIVIDEND